Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 140,000-145,000 insulin-dependent diabetics are using it worldwide.
| Website: | www.insulet.com |
| Email: | ir@insulet.com |
| Main Phone: | +1 978 600-7000 |
| Address: | 100 Nagog Park |
| Address 2: | Suite 200 |
| State: | MA |
| City / Town: | Acton |
| Country: | USA |
| Postal Code: | 01720 |
| Exchange: | NGS |
| CEO: | Shacey Petrovic |
| Employees: | 1169 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
Nearly 80% of the 30 million diabetics in the U.S. still manage their insulin by what’s known as the multiple daily injection (MDI) method.
The Dow Jones Industrial Average traded down to 12,367.72 then approached 12,500 going into the final half hour of trading. The NASDAQ traded down to 2774.76 then approached 2850 going into the
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and a wireless personal diabetes manager that controls the dosage and has an integrated blood glucose meter. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 140,000-145,000 insulin-dependent diabetics are using it worldwide.
| Website: | www.insulet.com |
| Email: | ir@insulet.com |
| Main Phone: | +1 978 600-7000 |
| Address: | 100 Nagog Park |
| Address 2: | Suite 200 |
| State: | MA |
| City / Town: | Acton |
| Country: | USA |
| Postal Code: | 01720 |
| Exchange: | NGS |
| CEO: | Shacey Petrovic |
| Employees: | 1169 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
Nearly 80% of the 30 million diabetics in the U.S. still manage their insulin by what’s known as the multiple daily injection (MDI) method.
The Dow Jones Industrial Average traded down to 12,367.72 then approached 12,500 going into the final half hour of trading. The NASDAQ traded down to 2774.76 then approached 2850 going into the
| Last Price 193.01 | Change $ 0.45 | Change % 0.23 | Tick N/A |
| Bid 192.18 | Bid Size 100.00 | Ask 223.96 | Ask Size 100.00 |
| Open 189.37 | High 193.51 | Low 188.11 | Prev Close 192.56 |
| Last Trade | Volume 389,213 | 52 Wk Hi 193.97 | 52 Wk Low 75.20 |
| Market Cap 11.9 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 61,821,566.00 | EPS (TTM) 0.26 | PE Ratio 740.60 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 33 | 98 |
| Number of Buys | 14 | 39 |
| Number of Sells | 19 | 59 |
| Net Activity | -21594 | 187800 |
| Last 10 Buys | Shares |
|---|---|
| James C. Mullen | 1,000 |
| Charles Alpuche | 1,000 |
| Michael P. Spears | 1,000 |
| Jessica Hopfield | 1,000 |
| Brad Thomas | 1,000 |
| Charles Alpuche | 1,000 |
| Patrick J. Sullivan | 1,000 |
| Brad Thomas | 1,000 |
| Patrick J. Sullivan | 1,000 |
| Patrick J. Sullivan | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Michael P. Spears | 1,000 |
| Michael P. Spears | 1,000 |
| Shacey Petrovic | 1,000 |
| Michael P. Spears | 1,000 |
| Michael P. Spears | 1,000 |
| Michael P. Spears | 1,000 |
| Michael P. Spears | 1,000 |
| David Colleran | 1,000 |
| Michael P. Spears | 1,000 |
| Michael P. Spears | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 106 | 106 | 105 | 106 |
| Low Target Price Estimate | 81 | 81 | 81 | 81 |
| Mean Target Price Estimate | 97.44 | 97.44 | 95.88 | 97.44 |
| Standard Deviation | 7.05 | 7.05 | 7.28 | 7.05 |
| Date of Most Recent Estimate | 06/04/18 | 06/04/18 | 05/25/18 | 06/04/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-14 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-31 |
| SD | Specialized Disclosure Report | 8 | 2018-05-31 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-22 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 12 | 12 | 13 | 11 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 6 | 6 | 5 | 6 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.68 | 1.68 | 1.58 | 1.72 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait